Enterprise Financial Services Corp Novartis Ag Transaction History

Enterprise Financial Services Corp

$177 Million
Q4 2024

A detailed history of Enterprise Financial Services Corp transactions in Novartis Ag stock. As of the latest transaction made, Enterprise Financial Services Corp holds 3,016 shares of NVS stock, worth $348,559. This represents 0.17% of its overall portfolio holdings.

Number of Shares

3,016

Previous 2,856 5.6%

Holding current value

$348,559

Previous $328,000 10.67%

% of portfolio

0.17%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$96.78 - $117.18 $15,484 - $18,748	160 Added 5.6%	3,016 $293,000
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $6,367 - $7,253	-60 Reduced 2.06%	2,856 $328,000
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $32,214 - $37,364	-348 Reduced 10.66%	2,916 $310,000
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $4,954 - $5,640	-52 Reduced 1.57%	3,264 $315,000
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $16,793 - $18,480	182 Added 5.81%	3,316 $334,000
Q3 2023 Oct 31, 2023	BUY	$94.73 - $105.13 $3,315 - $3,679	35 Added 1.13%	3,134 $319,000
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $6,939 - $7,868	-75 Reduced 2.36%	3,099 $312,000
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $12,404 - $14,385	155 Added 5.13%	3,174 $292,000
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $2,795 - $3,423	-37 Reduced 1.21%	3,019 $273,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $4,327 - $5,061	-58 Reduced 1.86%	3,056 $232,000
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $12,963 - $15,093	161 Added 5.45%	3,114 $263,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $18,265 - $20,661	228 Added 8.37%	2,953 $259,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $40,886 - $45,210	-513 Reduced 15.84%	2,725 $238,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $42,607 - $49,567	521 Added 19.18%	3,238 $265,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $36,823 - $40,672	-432 Reduced 13.72%	2,717 $247,000
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $8,099 - $9,551	97 Added 3.18%	3,149 $269,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $156 - $188	-2 Reduced 0.07%	3,052 $288,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $22,917 - $25,389	-279 Reduced 8.37%	3,054 $266,000
Q2 2020 Aug 04, 2020	BUY	$80.93 - $91.1 $52,523 - $59,123	649 Added 24.18%	3,333 $291,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $46,147 - $64,653	-653 Reduced 19.57%	2,684 $221,000
Q4 2019 Jan 28, 2020	BUY	$84.35 - $95.37 $49,513 - $55,982	587 Added 21.35%	3,337 $316,000
Q2 2019 Jul 30, 2019	BUY	$75.4 - $92.8 $3,543 - $4,361	47 Added 1.74%	2,750 $251,000
Q1 2019 Apr 26, 2019	BUY	$75.32 - $86.15 $9,264 - $10,596	123 Added 4.77%	2,703 $260,000
Q3 2018 Oct 26, 2018	SELL	$66.94 - $77.43 $10,308 - $11,924	-154 Reduced 5.63%	2,580 $222,000
Q2 2018 Jul 27, 2018	SELL	$64.91 - $73.36 $714 - $806	-11 Reduced 0.4%	2,734 $207,000
Q1 2018 Apr 27, 2018	BUY	$70.39 - $84.15 $11,684 - $13,968	166 Added 6.44%	2,745 $222,000
Q3 2017 Oct 27, 2017	BUY	$74.14 - $77.27 $191,207 - $199,279	2,579	2,579 $221,000

Others Institutions Holding NVS

# of Institutions

1,479

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.

Account

Enterprise Financial Services Corp Novartis Ag Transaction History